Loading... Please wait...

CytomX Therapeutics, Inc. (CTMX) Financials

Currency in USD Disclaimer
$1.29 -$0.01 (-0.77%)
$1.27
$1.31
$1.04
$5.85
Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Operating Revenue $101.21 M $53.16 M $69.57 M $100.36 M $57.49 M $59.50 M $71.62 M $15.04 M $7.71 M $5.08 M
Cost of Revenue $2.18 M $5.86 M $5.84 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit $99.04 M $47.31 M $63.73 M $100.36 M $57.49 M $59.50 M $71.62 M $15.04 M $7.71 M $5.08 M
Gross Profit Ratio 0.98 0.89 0.92 1 1 1 1 1 1 1
Research and Development Expenses $75.65 M $111.65 M $114.19 M $112.94 M $131.62 M $103.87 M $92.28 M $54.76 M $28.36 M $28.30 M
General & Administrative Expenses $30.02 M $42.85 M $39.16 M $36.03 M $36.77 M $33.51 M $25.61 M $19.87 M $12.56 M $6.54 M
Selling & Marketing Expenses -$146,000.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $29.87 M $42.85 M $39.16 M $36.03 M $36.77 M $33.51 M $25.61 M $19.87 M $12.56 M $6.54 M
Other Expenses -$30,000.00 $340,000.00 -$83,000.00 -$27,000.00 -$135,000.00 -$68,000.00 -$27,000.00 -$69,000.00 -$1.74 M -$55,000.00
Operating Expenses $105.52 M $154.50 M $153.35 M $148.97 M $168.38 M $137.38 M $117.88 M $74.63 M $40.92 M $34.84 M
Cost And Expenses $107.70 M $154.50 M $153.35 M $148.97 M $168.38 M $137.38 M $117.88 M $74.63 M $40.92 M $34.84 M
Interest Income $9.84 M $1.68 M $255,000.00 $1.84 M $8.37 M $7.64 M $2.67 M $2.43 M $1.32 M $7,000.00
Interest Expense $0.00 -$2.02 M $0.00 $0.00 $0.00 $0.00 $0.00 $1.69 M $1.73 M $487,000.00
Depreciation & Amortization $2.18 M $2.44 M $2.71 M $2.57 M $2.61 M $1.88 M $1.65 M $1.73 M $1.21 M $783,000.00
EBITDA -$4.31 M -$101.34 M -$83.78 M -$46.03 M -$110.90 M -$75.99 M -$44.61 M -$55.50 M -$32.43 M -$29.03 M
EBITDA Ratio -0.04 -1.91 -1.2 -0.46 -1.93 -1.28 -0.62 -3.69 -4.2 -5.72
Operating Income -$6.48 M -$101.34 M -$83.78 M -$48.61 M -$110.90 M -$77.87 M -$46.26 M -$59.59 M -$33.20 M -$29.77 M
Operating Income Ratio -0.06 -1.91 -1.2 -0.48 -1.93 -1.31 -0.65 -3.96 -4.31 -5.86
Total Other Income/Expenses Net $9.81 M $2.02 M $172,000.00 $1.81 M $8.23 M -$68,000.00 -$27,000.00 -$69,000.00 -$1.74 M -$55,000.00
Income Before Tax $3.32 M -$99.32 M -$83.61 M -$46.80 M -$102.67 M -$70.30 M -$43.61 M -$58.92 M -$35.36 M -$30.30 M
Income Before Tax Ratio 0.03 -1.87 -1.2 -0.47 -1.79 -1.18 -0.61 -3.92 -4.59 -5.97
Income Tax Expense $3.89 M -$2.02 M -$2.96 M -$13.91 M -$427,000.00 $14.30 M -$513,000.00 -$19,000.00 $10,000.00 $10,000.00
Net Income -$569,000.00 -$97.30 M -$80.65 M -$32.89 M -$102.24 M -$84.60 M -$43.10 M -$58.90 M -$35.37 M -$30.31 M
Net Income Ratio -0.01 -1.83 -1.16 -0.33 -1.78 -1.42 -0.6 -3.92 -4.59 -5.97
EPS -0.0077 -1.48 -1.26 -0.71 -2.26 -2.03 -1.16 -1.63 -4.12 -0.87
EPS Diluted -0.0077 -1.48 -1.26 -0.71 -2.26 -2.03 -1.16 -1.63 -4.12 -0.87
Weighted Average Shares Out $73.81 M $65.74 M $64.15 M $46.15 M $45.34 M $41.66 M $37.17 M $36.23 M $8.60 M $34.92 M
Weighted Average Shares Out Diluted $73.81 M $65.74 M $64.15 M $46.15 M $45.34 M $41.66 M $37.17 M $36.23 M $8.60 M $34.92 M
Link
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Log In


or

Continue with Google Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.